NV

Novartis AG Sponsored ADR (NVSN)

BMV

Currency in MXN
2,677.00
0.00 (0.00%)

Closed

Aug 21, 2026

Day's Range

2,677.00
2,677.00

52 wk Range

2,206.00
2,866.83

Overview - NVSN - Novartis AG Sponsored ADR

Key Statistics

Valuation

Enterprise Value

86.67T

P/E (Trailing)

‪23.86‬

PEG Ratio

‪-1.37‬

Price / Sales (TTM)

‪89.75‬

Price / Book

‪7.19‬

EV / EBITDA

‪222.09‬

Profitability

Gross Margin

‪75.18%‬

Profit Margin

‪22.50%‬

Operating Margin

‪34.62%‬

Return on Assets

‪10.25%‬

Return on Equity

‪30.35%‬

Ownership

Shares Outstanding

1.90B

Float

1.85B

Held by Insiders

‪0.01%‬

Held by Institutions

‪7.26%‬

Price stats

Beta

‪0.49‬

50-Day Avg

‪2,689.88‬

200-Day Avg

‪2,625.52‬

Dividends

Payout Ratio

‪71.59%‬

Frequency

Annual

Market Cap - NVSN - Novartis AG Sponsored ADR

Peers - NVSN - Novartis AG Sponsored ADR

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on BMV.

Profile Summary - NVSN - Novartis AG Sponsored ADR

About

Novartis AG Sponsored ADR represents ownership in Novartis AG, a global healthcare company focused on researching, developing, manufacturing, and marketing innovative medicines. Through this ADR structure, U.S. investors can gain exposure to Novartis AG shares in U.S. dollars, with each depositary receipt backed by an…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees75.88K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.